Wang, Kaibin
Wei, Shiyao
Hou, Dingkun
Wang, Lili
Kang, Lijuan
Li, Hongzheng
Li, Changying
Wang, Haitao
Funding for this research was provided by:
Clinical Research of Tianjin Medical University (No: 2018kylc004)
Tianjin Key Medical DisciplineConstruction Project (Grant No.TJYXZDXK-3-003A)
Article History
Received: 25 December 2025
Accepted: 13 February 2026
First Online: 18 February 2026
Declarations
:
: This study solely involved secondary analysis of publicly available, de-identified data from The Cancer Genome Atlas and the Gene Expression Omnibus, with no direct involvement of human or animal subjects. Therefore, additional approval from an institutional ethics committee was not required. The data used in this study were sourced from public databases. Informed consent for participation was obtained from all participants in the original studies during initial data collection. No additional consent was required for this secondary analysis of de-identified data.
: Consent for publication of the data was obtained within the original studies at the time of their dataset deposition. No additional consent for publication was required for this secondary analysis of the de-identified data.
: The authors declare no competing interests.